29/06/2025
đź”´ Urgent Public Health Need in India
Late Diagnosis: Over 60% of breast cancer cases in India are diagnosed at Stage III or IV, drastically reducing survival rates.
High Mortality: India has one of the highest breast cancer mortality rates globally due to lack of early detection.
⚕️ Lack of Infrastructure in Rural & Semi-Urban Areas
Shortage of Radiologists: Mammography is not widely available, and trained professionals are concentrated in urban hospitals.
Access Barriers: Long travel distances, lack of awareness, cultural stigma, and cost limit screening participation.
đźšş Rising Incidence Among Younger Women
Breast cancer is now more common in Indian women in their 30s and 40s, unlike in the West where it typically affects older women. Early and regular screening is critical for this younger demographic.
đź’ˇ Why a Point-of-Care Screening Kit?
Non-invasive, fast, and portable — ideal for deployment in primary health centers, health camps, and mobile clinics.
Requires minimal training, making it usable by frontline health workers (ASHAs, ANMs).
Cost-effective and scalable, especially when combined with digital health tools and AI.
🔬 BioLink Therapeutics' Mission
BioLink Therapeutics is addressing this critical gap by licensing a groundbreaking U.S.-developed liquid biopsy technology — a 15-minute non-invasive breast cancer screening kit — to be piloted in India. It’s set to revolutionize early detection, especially in under-resourced settings, and could dramatically improve survival outcomes through early intervention and accessibility. BioLink team is actively engaging with VCs with a focus of raising seed fund.
https://lnkd.in/eKHE9h9y